Anti-VEGF Treatment Strategies for Wet AMD
Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2012/786870 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552315032174592 |
|---|---|
| author | Jaclyn L. Kovach Stephen G. Schwartz Harry W. Flynn Ingrid U. Scott |
| author_facet | Jaclyn L. Kovach Stephen G. Schwartz Harry W. Flynn Ingrid U. Scott |
| author_sort | Jaclyn L. Kovach |
| collection | DOAJ |
| description | Over the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies. |
| format | Article |
| id | doaj-art-aaddc2b96a4043a1ac1613d4d7dd7e35 |
| institution | Kabale University |
| issn | 2090-004X 2090-0058 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Ophthalmology |
| spelling | doaj-art-aaddc2b96a4043a1ac1613d4d7dd7e352025-02-03T05:59:04ZengWileyJournal of Ophthalmology2090-004X2090-00582012-01-01201210.1155/2012/786870786870Anti-VEGF Treatment Strategies for Wet AMDJaclyn L. Kovach0Stephen G. Schwartz1Harry W. Flynn2Ingrid U. Scott3Department of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami, 311 9th St North, Naples, FL 34102, USADepartment of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami, 311 9th St North, Naples, FL 34102, USADepartment of Ophthalmology, Bascom Palmer Eye Institute, School of Medicine, University of Miami, 311 9th St North, Naples, FL 34102, USAPenn State Hershey Eye Center, Hershey, PA 17033, USAOver the past few years, antivascular endothelial growth factor (VEGF) therapy has become a standard treatment for neovascular age-related macular degeneration (AMD). During this time, treatment strategies have evolved from a monthly dosing schedule to individualized regimens. This paper will review the currently available anti-VEGF agents and evidence-based treatment strategies.http://dx.doi.org/10.1155/2012/786870 |
| spellingShingle | Jaclyn L. Kovach Stephen G. Schwartz Harry W. Flynn Ingrid U. Scott Anti-VEGF Treatment Strategies for Wet AMD Journal of Ophthalmology |
| title | Anti-VEGF Treatment Strategies for Wet AMD |
| title_full | Anti-VEGF Treatment Strategies for Wet AMD |
| title_fullStr | Anti-VEGF Treatment Strategies for Wet AMD |
| title_full_unstemmed | Anti-VEGF Treatment Strategies for Wet AMD |
| title_short | Anti-VEGF Treatment Strategies for Wet AMD |
| title_sort | anti vegf treatment strategies for wet amd |
| url | http://dx.doi.org/10.1155/2012/786870 |
| work_keys_str_mv | AT jaclynlkovach antivegftreatmentstrategiesforwetamd AT stephengschwartz antivegftreatmentstrategiesforwetamd AT harrywflynn antivegftreatmentstrategiesforwetamd AT ingriduscott antivegftreatmentstrategiesforwetamd |